Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Brain tumor chemotherapy using a rat glioma model.

M Tamura, H D Mennel, K J Zülch

    Journal of Cancer Research and Clinical Oncology
    |May 14, 1979
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    [Unclassified brain tumors].

    Acta neurochirurgica·2014
    Same author

    Two novel cell specific receptor proteins, CRLR and CD 117 in human glial tumors.

    Clinical neuropathology·2006
    Same author

    Comparative experimental study of argon plasma and bipolar coagulation techniques.

    Acta neurochirurgica·2006
    Same author

    [Clinical implications of meningococcal disease].

    Deutsche medizinische Wochenschrift (1946)·2006
    Same author

    Ganglioside (GD2) expression and intermediary filaments in astrocytic tumors.

    Clinical neuropathology·2005
    Same author

    Argon plasma coagulation (APC) in brain tumor surgery: experimental study and clinical experiences.

    Clinical neuropathology·2004

    Chloroethylcyclohexyl-nitrosourea (CCNU) effectively extended lifespan in a rat glioma model. Optimal dosage increased survival significantly, while sub-therapeutic or toxic doses showed limited efficacy or adverse effects.

    Area of Science:

    • Oncology
    • Pharmacology
    • Neuroscience

    Background:

    • Glioblastoma is an aggressive brain tumor with limited treatment options.
    • Nitrosoureas, like CCNU, are chemotherapeutic agents used in cancer treatment.
    • Understanding CCNU's efficacy and toxicity in a relevant preclinical model is crucial.

    Purpose of the Study:

    • To evaluate the efficacy of chloroethylcyclohexyl-nitrosourea (CCNU) in a rat glioma model.
    • To determine the optimal dosage and toxicity profile of CCNU.
    • To investigate the histopathological changes induced by CCNU in glioma tumors.

    Main Methods:

    • A rat glioma model was established.
    • Chloroethylcyclohexyl-nitrosourea (CCNU) was administered intraperitoneally at various dosages.

    Related Experiment Videos

  • Survival rates and lifespan extension were measured.
  • Hematological parameters (platelets, white blood cells) and tumor histopathology were analyzed.

    • Main Results:

    • A regimen of three 40 mg/kg CCNU doses significantly increased lifespan (53% to 86%).
    • Doses below 30 mg/kg were ineffective.
    • Higher doses exceeding LD10 exhibited toxicity.
    • Mild, reversible depression of platelets and white blood cells was observed.
    • CCNU treatment increased tumor necrobiosis, cellular ballooning, nuclear pyknosis, and microcystic changes.

    Conclusions:

    • CCNU demonstrates significant antitumor activity and lifespan extension in a rat glioma model at specific dosages.
    • A therapeutic window exists for CCNU, with sub-therapeutic doses being ineffective and high doses being toxic.
    • CCNU induces characteristic cytotoxic and degenerative changes in glioma cells.